CSI Market
Sign In | Register

Bohai Pharmaceuticals Group (BOPH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BOPH Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Bohai Pharmaceuticals Group adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2014)
3 Months 		(Jun 30 2014) (Mar 31 2014) (Dec 31 2013) (Sep 30 2013)
Operating Activities
Income9.34
Depreciation & amortization1.66
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.74
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Accretion Of Beneficial Conversion Feature-
Allowance For Loan And Lease Losses Recoveries Of Bad Debts-
Indefinite Lived Intangible Assets Impairment Losses-
Other Receivable And Prepayments0.35
Income taxes2.20
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable3.97
Increase (Decrease) in Accounts Payable0.50
Increase (Decrease) in Accrued Liabilities-3.30
Increase (Decrease) in Customer Advances0.00
Increase (Decrease) in Prepaid Expense and Other Assets-7.49
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities6.49
Investing Activities
Capital Expenditures-2.66
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Leased L and Use Rights-
Purchase Of Formulas-
Property Plant And Equipment Deposits-
Payments to Acquire Restricted Certificates of Deposit0.00
Payments for (Proceeds from) Loans0.00
Proceeds from Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.66
Financing Activities
Short-term debt Net9.74
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-9.74
Deposit Of Restricted Cash Note Payable-
Deposit Of Restricted Cashconvertible Note Escrow Deposit-
Release Of Restricted Cashconvertible Note Escrow Deposit-
Deposit Of Restricted Cash Convertible Note Escrow Deposit-
Release Of Restricted Cash Convertible Note Escrow Deposit-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.01
Discontinued operations0.00
Free Cash Flow3.82
Total Cash Flow3.83
4 historic quarters locked

Sign in to unlock the full Bohai Pharmaceuticals Group cash flow history.

Sign In Create Free Account

About BOPH Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.